* Study identifies patients who would benefit from redifferentiation therapy for thyroid cancer

https://www.mayoclinic.org/medical-professionals/endocrinology/news/study-identifies-patients-who-would-benefit-from-redifferentiation-therapy-for-thyroid-cancer/mac-20592451

* BRAF and MEK Inhibition Beyond Dabrafenib-Trametinib in Advanced Thyroid Cancer

https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2026.1694805/full

* Cli ...